Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
9.35
+0.74 (8.59%)
At close: Mar 26, 2026, 4:00 PM EDT
9.79
+0.44 (4.71%)
Pre-market: Mar 27, 2026, 4:01 AM EDT
Armata Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Armata Pharmaceuticals stock have an average target of 15, which predicts a 60.43% increase from the current stock price of 9.35.
Price Target: $15 (+60.43%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 23, 2026.
Analyst Ratings
The average analyst rating for Armata Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $15 | Strong Buy | Maintains | $9 → $15 | +60.43% | Feb 23, 2026 |
| Jones Trading | Jones Trading | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +60.43% | Jan 5, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $9 | Strong Buy | Maintains | $7 → $9 | -3.74% | May 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | -25.13% | Dec 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | -25.13% | Nov 14, 2024 |
Financial Forecast
Revenue This Year
4.64M
from 5.17M
Decreased by -10.30%
Revenue Next Year
n/a
from 4.64M
EPS This Year
-1.67
from -0.89
EPS Next Year
-1.11
from -1.67
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.6M | n/a | |||
| Avg | 4.6M | n/a | |||
| Low | 3.7M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 7.6% | - | |||
| Avg | -10.3% | - | |||
| Low | -28.0% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.62 | -1.14 | |
| Avg | -1.67 | -1.11 | |
| Low | -1.70 | -1.07 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.